Publications by authors named "Jian-Qing Mi"

Claim this Profile
A
A First-In-Human Phase 1 Study of a Novel BCMA×CD3 Bispecific T Cell Engager EMB-06 in Relapsed or Refractory Multiple Myeloma.
Peter T Tan, Li Bao, Qingsong Yin, Chunrui Li, Sorab Jehangir Shavaksha, Henry Miles Prince, Mingfei Zhang, Jian-Qing Mi

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR::ABL1-Like B-Cell Acute Lymphoblastic Leukemia with BCR::PDGFRA Fusion: A Case Report and Literature Review.
Jiamin Hua, Han Yan, Xiangyu Qian, Dongyan Gao, Bo Yang, Jian-Qing Mi

Acta Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-5 is an adjunctive biomarker for engraftment syndrome in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.
Xing-Li Zhang, Meng-Meng Pan, Yaroslav Kaminskiy, Shi-Wei Jin, Jian-Qing Mi

Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma.
Mengmeng Pan, Di Wang, Jie Xu, Shiwei Jin, Yan Wang, Jian-Qing Mi

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of novel therapies for refractory and relapsed multiple myeloma in China: A scoping systematic review.
Jie Xu, Shiwei Jin, Yan Wang, Yuanfang Liu, Yi Tao, Jian-Qing Mi

Chin Med J (Engl)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Characteristics and Risk Analysis of COVID-19 Infection in Patients with Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation].
Meng-Meng Pan, Shi-Wei Jin, Wan-Yan Ouyang, Yan Wan, Yi Tao, Jian-Qing Mi

Zhongguo Shi Yan Xue Ye Xue Za Zhi· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges facing CAR T-cell immunotherapy in multiple myeloma.
Wanyan Ouyang, Jian-Qing Mi

Crit Rev Oncol Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of [F]fluorodeoxyglucose-PET/MRI(CT) novel interpretation criteria (IMPeTUs) in multiple myeloma.
Miao Zhang, Tangjia Cai, Shiwei Jin, Xinyun Huang, Yuting Gao, Jian-Qing Mi

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL.
Qing Xue, Ming Zhang, Yixiao Mo, Bo Jiao, Xuan Liu, Minghao Jiang, Huimin Li, Jianming Zhang, Jian-Qing Mi

Signal Transduct Target Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: BCMA-targeting CAR T-cell therapy induces complete and durable remission in relapsed extramedullary plasmablastic multiple myeloma.
Lili Zhou, Paul Ning Man Cheng, Jian-Qing Mi

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics.
Yi Tao, Shi-Wei Jin, Zhe Wang, Mengmeng Pan, Wanyan Ouyang, Jian-Qing Mi

BMC Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia.
Shanshan Guo, Ekaterina Bourova-Flin, Sophie Rousseaux, Florent Chuffart, Lijun Peng, Jian-Qing Mi

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.
Jun-Yu Wang, Tuan-Tuan Gui, Bo Jiao, Xuan Liu, Xiao-Lin Ma, Ming Zhang, Jian-Qing Mi

Proc Natl Acad Sci U S A· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma.
Yan Wang, Yuan-Fang Liu, Shi-Wei Jin, Yi Tao, Wei-Ping Zhang, Jian-Qing Mi

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in China.
Jing Luo, Jiaojiao Zhang, Ligen Liu, Rong Wei, Yonghua Yao, Min Xu, Jianmin Yang, Jian-Qing Mi

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of olverembatinib in adult BCR::ABL1-positive ALL with T315I mutation or relapsed/refractory disease.
Weiyang Liu, Cheng Wang, Wanyan Ouyang, Jie Hao, Jiayi Ren, Jian-Qing Mi

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical Trial.
Chunrui Li, Keshu Zhou, Yongxian Hu, Dehui Zou, Lijuan Chen, Jian-Qing Mi

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.
Dominik Beck, Honghui Cao, Feng Tian, Yizhou Huang, Miao Jiang, Jian-Qing Mi

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression.
Wenqian Xu, Feng Tian, Xiaolu Tai, Gaoxian Song, Yuanfang Liu, Jian-Qing Mi

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China.
Wenyan Yu, Liang Huang, Heng Mei, Yuhua Li, Ting Niu, Jian-Qing Mi

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion.
Wanyan Ouyang, Shi-Wei Jin, Nan Xu, Wei-Yang Liu, Han Zhao, Jian-Qing Mi

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
Jie Tian, Yong-Ping Song, Gao-Chong Zhang, Shu-Fang Wang, Xiao-Xiang Chu, Jian-Qing Mi

J Cancer Res Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia.
Cheng Wang, Jianfeng Li, Weiyang Liu, Lingling Zhao, Han Yan, Jian-Qing Mi

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial.
Jie Xu, Bai-Yan Wang, Shan-He Yu, Shi-Jun Chen, Shuang-Shuang Yang, Jian-Qing Mi

J Hematol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma.
Shuangshuang Yang, Jie Xu, Yuting Dai, Shiwei Jin, Yan Sun, Jian-Qing Mi

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis